Add to ORKGThe present invention concerns a nanoparticle comprising a block copolymer, which includes a hydrophilic block and a lipophilic block. The nanoparticle according to the invention can be efficiently loaded with a therapeutic agent, such as trabectedin or paclitaxel, which are well-known anticancer drugs. The present invention also concerns a very simple method of making such a nanoparticle which envisages only the use of conventional syringe and laboratory glassware.
The present invention refers to a nanovesicle comprising a sterol and a non-lipid cationic surfactan...
In the current study, 5-FU-loaded nanoparticles (NPs) were prepared using polylactic-co-glycolic aci...
The technological development of biodegradable nanoparticles for drug delivery in medical diagnostic...
The present invention concerns a nanoparticle comprising a block copolymer, which includes a hydroph...
The improvement of the pharmacological profile of lipophilic drug formulations is one of the main su...
The improvement of the pharmacological profile of lipophilic drug formulations is one of the main su...
Delivery of the anticancer drug paclitaxel (commercially known as Taxol®) is difficult due to its li...
Development of nanotechnology in medicine, and more precisely drug delivery, has provided attractive...
Paclitaxel is a microtubule inhibitor causing mitotic arrest and is widely used in cancer chemothera...
The advent of nanotechnology in medicine has allowed to eliminate the toxic excipients that are ofte...
[ES] La presente invención se refiere a nanopartículas de fórmula (I) para el direccionamiento activ...
The present invention relatesto a nanoparticle having a size comprised from 2 to 300 nm comprising: ...
La délivrance contrôlée de médicaments constitue un enjeu thérapeutique de première importance pour ...
Lo scopo della ricerca è stato trovare nuove formulazioni che permettano di aumentare la biodisponib...
Os vectores coloidais de natureza lipídica têm atraído particular atenção para o desenvolvimento de...
The present invention refers to a nanovesicle comprising a sterol and a non-lipid cationic surfactan...
In the current study, 5-FU-loaded nanoparticles (NPs) were prepared using polylactic-co-glycolic aci...
The technological development of biodegradable nanoparticles for drug delivery in medical diagnostic...
The present invention concerns a nanoparticle comprising a block copolymer, which includes a hydroph...
The improvement of the pharmacological profile of lipophilic drug formulations is one of the main su...
The improvement of the pharmacological profile of lipophilic drug formulations is one of the main su...
Delivery of the anticancer drug paclitaxel (commercially known as Taxol®) is difficult due to its li...
Development of nanotechnology in medicine, and more precisely drug delivery, has provided attractive...
Paclitaxel is a microtubule inhibitor causing mitotic arrest and is widely used in cancer chemothera...
The advent of nanotechnology in medicine has allowed to eliminate the toxic excipients that are ofte...
[ES] La presente invención se refiere a nanopartículas de fórmula (I) para el direccionamiento activ...
The present invention relatesto a nanoparticle having a size comprised from 2 to 300 nm comprising: ...
La délivrance contrôlée de médicaments constitue un enjeu thérapeutique de première importance pour ...
Lo scopo della ricerca è stato trovare nuove formulazioni che permettano di aumentare la biodisponib...
Os vectores coloidais de natureza lipídica têm atraído particular atenção para o desenvolvimento de...
The present invention refers to a nanovesicle comprising a sterol and a non-lipid cationic surfactan...
In the current study, 5-FU-loaded nanoparticles (NPs) were prepared using polylactic-co-glycolic aci...
The technological development of biodegradable nanoparticles for drug delivery in medical diagnostic...